Untch, Michael
Helios Hospital Berlin-Buch
4 papers on CoChatORCID 0000-0002-1233-1267
Most cited papers
- Verified
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine
HER2/EGFR in Cancer ResearchBreast Cancer Treatment Studies
Cited by 5,084
- Verified
Pembrolizumab for Early Triple-Negative Breast Cancer
Schmid, P., Cortes, J., Pusztai, L., McArthur, H., Kümmel, S., Bergh, J., Denkert, C., Park, Y. H., Hui, R., Harbeck, N., et al. (2020) · New England Journal of Medicine
Breast Cancer Treatment StudiesCancer Immunotherapy and Biomarkers
Cited by 3,270
- Verified
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
von Minckwitz, G., Untch, M., Blohmer, J.-U., Costa, S. D., Eidtmann, H., Fasching, P. A., Gerber, B., Eiermann, W., Hilfrich, J., Huober, J., et al. (2012) · Journal of Clinical Oncology
Breast Cancer Treatment StudiesBreast Lesions and Carcinomas
Cited by 2,659
- Verified
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
Denkert, C., von Minckwitz, G., Darb-Esfahani, S., Lederer, B., Heppner, B. I., Weber, K. E., Budczies, J., Huober, J., Klauschen, F., Furlanetto, J., et al. (2018) · The Lancet Oncology
Breast Cancer Treatment StudiesBreast Lesions and Carcinomas
Cited by 2,157
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free